Clinical Diagnostics MasterFile

    Published: August 30, 2021 | Price:

    More than 42,000 Instruments at over 5,000 Facilities across a Dozen Modalities — 12 Month License with Quarterly Refresh Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities: Blood Gas Analyzers Chemistry Coagulation HbA1c Hematology Immunoassay Integrated Chem/Immuno Mass Spectrometry Microbiology AST ID Microbiology Blood Culture Molecular Diagnostics Next-Generation Sequencing Urinalysis Analyzers...
    The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition

    Published: July 29, 2021 | Price: $8,250.00 – $16,500.00

    Kalorama Information's latest edition of our in vitro diagnostic market report is now available.  This represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers.  Last year, the COVID-19 pandemic highlighted how important testing is in a way that could not be imagined  This year, COVID-19 is to some degree a routine test category in respiratory and infectious disease testing, themselves high-growth segments.   Now the question will be...
    The Market for In Vitro Diagnostic Tests in Latin America

    Published: June 29, 2021 | Price: $4,000.00 – $8,000.00

    Latin America (LATAM) is a key target for IVD manufacturers exploring expansion opportunities.   This report, The Market for In Vitro Diagnostic Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador,...
    The World Market for Molecular Diagnostics Tests, 10th Edition (NGS, PCR, NAAT, ISH, TMA, Other)

    Published: June 17, 2021 | Price: $5,000.00 – $10,000.00

    Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...
    Clinical Laboratory Services Market, 6th Edition

    Published: June 8, 2021 | Price: $4,000.00 – $8,000.00

    Clinical Laboratory Services Market, 6th Edition, new from Kalorama Information, provides an overview of the clinical laboratory industry and the trends driving growth.  Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies.  Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia...
    United States Market for In Vitro Diagnostic (IVD) Tests

    Published: June 7, 2021 | Price: $4,000.00 – $8,000.00

    The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...
    At-Home Testing: COVID-19 Trends and Future Potential

    Published: April 15, 2021 | Price: $3,000.00 – $6,000.00

    This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...
    The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition

    Published: April 13, 2021 | Price: $5,000.00 – $10,000.00

    By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually.  This should not be surprising.  Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing.  In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC  COVID-19 was stunning. Updated for COVID-19 Impacts In some segments, COVID-19 caused a contraction of the segment...
    The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)

    Published: March 23, 2021 | Price: $5,000.00 – $10,000.00

    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This report focuses on diagnostics.  The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024,...
    2021 IVD Market Update and COVID-19 Impact

    Published: March 12, 2021 | Price: $3,000.00 – $6,000.00

    What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...
    IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests

    Published: February 23, 2021 | Price: $4,000.00 – $8,000.00

    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business...
    COVID-19 Testing Update 2021: Molecular and Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends

    Published: February 16, 2021 | Price: $3,000.00 – $6,000.00

    As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently.  Hundreds of test products are on the market to detect the virus, both for its presence and immune response.  And billions of dollars have been added to the in vitro diagnostic market.  Companies have doubled and tripled revenues, bought new companies, increased manufacturing, shifted focus to infectious diseases and launched new products. "A 38 Billion Dollar Market...
    The Market and Potential for Molecular Point of Care 2021

    Published: January 22, 2021 | Price: $4,000.00 – $8,000.00

    This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...
    Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic Conditions

    Published: January 4, 2021 | Price: $4,000.00 – $8,000.00

    Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions. The area of inherited condition testing for neurological conditions has become a major area of activity in the last decade or so,...
    COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

    Published: November 2, 2020 | Price: $4,000.00 – $8,000.00

    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...